Michael Zaiac

Michael Zaiac, Head of Medical Oncology for Europe and Canada at Daiichi Sankyo, discusses how AI is revolutionizing clinical trials. He highlights the importance of advanced analytics for enhancing patient recruitment, improving eligibility, and fostering diversity in study populations. Michael also examines the role of generative AI in creating patient-friendly materials like simplified consent forms. Emphasizing stakeholder alignment and transparency, he underscores the need for responsible AI deployment in high-stakes environments.